Global Neurostimulation Devices Market - Strategic Insights and Forecasts (2026-2035)

The Neurostimulation Devices Market is valued at USD 4.92 billion in 2026 and is projected to reach USD 10.36 billion by 2035, growing at a CAGR of 8.6% during the forecast period.

The Neurostimulation Devices Market is driven by rising Parkinson’s disease prevalence, increasing cases of drug-resistant epilepsy, growing adoption of deep brain stimulation, and expansion of sensing-enabled and personalized neurostimulation technologies.

The Neurostimulation Devices Market faces challenges such as high device and implantation costs, limited access to specialized neurosurgical expertise, and long regulatory approval timelines for new technologies.

North America dominates the Neurostimulation Devices Market due to strong reimbursement systems, high neurological disease prevalence, advanced healthcare infrastructure, and early adoption of next-generation neuromodulation technologies.

Key companies in the Neurostimulation Devices Market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, NeuroPace, Inc., and Nevro Corp..